Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Myriam, Rosilio"'
Autor:
Imane Benabbad, Myriam Rosilio, Maité Tauber, Emmanuel Paris, Anne Paulsen, Lovisa Berggren, Hiren Patel, Jean-Claude Carel
Publikováno v:
Endocrine Connections, Vol 7, Iss 5, Pp 708-718 (2018)
Objective: There is a scarcity of data from randomised controlled trials on the association of growth hormone (GH) with gonadotrophin-releasing hormone agonists in idiopathic short stature (ISS), although this off-label use is common. We aimed to tes
Externí odkaz:
https://doaj.org/article/69478c1d6a074267841fd3ec72b4e3cb
Autor:
Nicolas, Naïditch, Christine, Mauchant, Imane, Benabbad, Coline, Hehn, Michael, Joubert, Jean-François, Thébaut, Myriam, Rosilio
Publikováno v:
Diabetes Therapy. 14:303-318
The use of devices to connect insulin pens could facilitate management and improve glycaemic control in people with type 1 (PwT1D) and type 2 diabetes (PwT2D). However, their acceptance seems little studied. We conducted an online survey with the mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b233ed4d039c93d40abd2e09fa96b77
https://doi.org/10.1007/s13300-022-01337-6
https://doi.org/10.1007/s13300-022-01337-6
Autor:
Francesco Giorgino, R. Gentilella, Marco Orsini Federici, Kristina S. Boye, Bruno Guerci, Hélène Sapin, U. Aigner, Luis-Emilio Garcia-Perez, Heike Jung, E. Heitmann, Kirsi Norrbacka, Myriam Rosilio
Publikováno v:
Diabetes Therapy
Introduction The TROPHIES observational study enrolled patients with type 2 diabetes mellitus (T2DM) initiating their first injectable treatment with the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) dulaglutide or liraglutide. This manuscrip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b3086660553c8107e7ebba45cb6e4b
https://doi.org/10.1007/s13300-021-01076-0
https://doi.org/10.1007/s13300-021-01076-0
Autor:
Hélène Sapin, Marco Orsini Federici, E. Heitmann, U. Aigner, Luis-Emilio Garcia-Perez, Myriam Rosilio, Kristina S. Boye, Kirsi Norrbacka, Francesco Giorgino, Heike Jung, Bruno Guerci
Publikováno v:
Diabetes Therapy
Introduction Although patient-reported outcome (PRO) measures provide important information beyond clinical data, studies that assess the PROs of type 2 diabetes mellitus (T2DM) patients initiating injectable glucose-lowering medications in routine c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b930fdac218b2bfe4e1a448e004f0aad
https://doi.org/10.1007/s13300-020-00908-9
https://doi.org/10.1007/s13300-020-00908-9
Autor:
Bruno Guerci, H Sapin, R. Gentilella, Heike Jung, Francesco Giorgino, Marco Orsini Federici, U. Aigner, KS Boye, Luis-Emilio Garcia-Perez, Kirsi Norrbacka, E. Heitmann, Myriam Rosilio
Publikováno v:
Präzisionsmedizin – Eine Reise in die Zukunft der Diabetologie www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75674ae10f4a40123b5c32d63cc30e69
https://doi.org/10.1055/s-0041-1727304
https://doi.org/10.1055/s-0041-1727304
Autor:
Bruno Guerci, H Sapin, Kirsi Norrbacka, E. Heitmann, Marco Orsini Federici, S. Zimner-Rapuch, KS Boye, U. Aigner, Luis-Emilio Garcia-Perez, Francesco Giorgino, Myriam Rosilio
Publikováno v:
Präzisionsmedizin – Eine Reise in die Zukunft der Diabetologie www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d04f2cb535f0108c7fedc988576105e8
https://doi.org/10.1055/s-0041-1727333
https://doi.org/10.1055/s-0041-1727333
Autor:
Bruno Guerci, Victoria Divino, Myriam Rosilio, Jeremie Lebrec, Mitch DeKoven, Kirsi Norrbacka, Sarah Zimner Rapuch, Kristina S. Boye
Publikováno v:
Diabetes Therapy
Introduction In type 2 diabetes (T2D), persistence with injectable glucose-lowering therapy is associated with better outcomes. This study used real-world pharmacy data to report on persistence with glucagon-like peptide-1 receptor agonists (GLP-1 RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23c8593aaf783cb0ca6382500fd05fd
https://pubmed.ncbi.nlm.nih.gov/33864629
https://pubmed.ncbi.nlm.nih.gov/33864629
Publikováno v:
Journal of the Endocrine Society. 5:A329-A329
Background: Understanding the extent and causes of suboptimal insulin dosing is key for the coordinated diabetes management. Integrating the benefits of monitoring, education, and clinical support can facilitate self-care among people with diabetes m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db30b97c98303d4edd205863d9916d45
https://doi.org/10.1210/jendso/bvab048.671
https://doi.org/10.1210/jendso/bvab048.671
Autor:
S. Zimner-Rapuch, E. Heitmann, Myriam Rosilio, M. Orsini Federici, KS Boye, Bruno Guerci, Kirsi Norrbacka, Federica Maria Giorgino, U. Aigner, Luis-Emilio Garcia-Perez, Hélène Sapin
Publikováno v:
Value in Health. 23:S506
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ca2aeb1386e08adb779f1ab9899bc70
https://doi.org/10.1016/j.jval.2020.08.600
https://doi.org/10.1016/j.jval.2020.08.600
Publikováno v:
Pediatric Diabetes. 18:81-94
Background Insulin lispro, the first rapid-acting insulin analog, was developed 20 years ago and has been studied in multiple situations and various populations. Objective To review the literature on the use of insulin lispro in children, adolescents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ae5f8387c699e15d67626e7052a1c58
https://doi.org/10.1111/pedi.12401
https://doi.org/10.1111/pedi.12401